TCTR20210814001Enrolling By Invitation3 期
Prucalopride for minimizing bowel ileus following ERCP with CO2 insufflation: A prospective randomize double-blinded placebo controlled trial
Srinagarind Hospital Khonkaen University0 个研究点目标入组 194 人开始时间: 2021年8月14日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- Enrolling By Invitation
- 发起方
- 入组人数
- 194
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Must have provided written informed consent prior to any screening procedures.
- •Male/female patient between 18 to 65 years of age at the time of informed consent who visit the clinic for having ERCP procedure.
排除标准
- •Suspected Intestinal obstruction or gastrointestinal leakage.
- •Contradicted to anesthetic agents.
- •Uncontrolled concomitant conditions; heart failure, hepatic failure, kidney failure, diabetes, hyperthyroidism or hypothyroidism.
- •Taking antiplatelets at least 7 days prior to enrollment
- •Taking warfarin at least 3 days prior to the enrollment
- •Pregnant women
- •Previous major surgery of gastrointestinal tract
- •Allergy to Prucalopride
- •Platelet normal
研究者
相似试验
Unknown
2 期
Prucalopride for Postoperative Ileus in Patients Undergoing Robot-assisted Laparoscopic Radical CystectomyPostoperative IleusBladder CancerNCT05001763The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School160
尚未招募
4 期
Role of Prucalopride treatment of chronic constipation in Parkinson diseaseConstipationParkinson's diseaseTCTR20200211001Faculty of Medicine, Siriraj Hospital80
进行中（未招募）
不适用
Prevention of constipation during treatment with opioids: magnesiumoxide versus macrogol/elektrolytesEUCTR2007-007610-10-NLMC Utrecht
已完成
3 期
Prevention of constipation during treatment with opioids: magnesiumoxide versus macrogol/elektrolytesConstipation/difficulty with bowel movements10017977NL-OMON33671niversitair Medisch Centrum Utrecht155
撤回
不适用
Clinical trial for amelioration of bowel uptake in PET/CTNeoplasmsKCT0001162Seoul National University Bundang Hospital300